This program is designed to continue their training and preparation of post-doctoral scientists and physicians for independent academic and research career in the field of connective tissue biochemistry and molecular biology. Post-doctoral fellows (M.D.s or Ph.D.s) will be trained for periods of up to two to three years in the approaches and methods currently applicable to connective tissue research. Special emphasis will continue to be placed on (a) the isolation and physiochemical characterization of extracellular matrix components, including collagens, elastin, microfibrillar components, fibronectin, laminins and proteoglycans, (2) the regulation of synthesis of the above components by cells in culture including fibroblasts, endothelial and smooth muscle cells, chondrocytes, keratinocytes, hematopoietic cells and neoplastic cell lines, (c) the regulated expression of genes encoding for extracellular matrix proteins during embryogenesis, and in disease states involving connective tissue macromolecules and (d) the regulation of the inflammatory response as well as tumor cell growth by connective tissue macromolecules including types I and IV collagens. Although, continuous monitoring of progress of trainees will be the responsibility of the individual trainer, the location of the program within the departments of Medicine, Dermatology, Biochemistry, Orthopaedic Surgery, Anatomy, Histology, and Animal Biology should assure to stimulate the trainees and maintain high quality and high standards. Trainees will be encouraged to broaden their experience by attending specialized courses and by working for short periods of time in the laboratory of one or more trainers. The strong interactions which have existed among the training faculty, both because of the long standing association among the trainers and their common research interests, should facilitate the lab rotations. Attendance, participation and presentation at frequent research seminars in connective tissue would constitute a key element of the training program. Four training positions are requested. Each participating training faculty member has adequate laboratory and animal facilities at his/her disposal to carry out research in the areas of protein chemistry, molecular biology, immunology, cell biology, tissue culture, light and electron microscopy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32AR007490-16
Application #
2821505
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Tyree, Bernadette
Project Start
1984-07-01
Project End
2004-04-30
Budget Start
1999-05-01
Budget End
2000-04-30
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Shahan, Tracy; Grant, Derrick; Tootell, Mason et al. (2004) Oncothanin, a peptide from the alpha3 chain of type IV collagen, modifies endothelial cell function and inhibits angiogenesis. Connect Tissue Res 45:151-63
Lin, Xiaoqing; Lubinski, John M; Friedman, Harvey M (2004) Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor. J Virol 78:2562-71
Rex, Tonia S; Allocca, Mariacarmela; Domenici, Luciano et al. (2004) Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Mol Ther 10:855-61
Li, D; Clark, C C; Myers, J C (2000) Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J Biol Chem 275:22339-47
Fawzi, A; Robinet, A; Monboisse, J C et al. (2000) A peptide of the alpha 3(IV) chain of type IV collagen modulates stimulated neutrophil function via activation of cAMP-dependent protein kinase and Ser/Thr protein phosphatase. Cell Signal 12:327-35
Shahan, T A; Fawzi, A; Bellon, G et al. (2000) Regulation of tumor cell chemotaxis by type IV collagen is mediated by a Ca(2+)-dependent mechanism requiring CD47 and the integrin alpha(V)beta(3). J Biol Chem 275:4796-802
Pasco, S; Han, J; Gillery, P et al. (2000) A specific sequence of the noncollagenous domain of the alpha3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells. Cancer Res 60:467-73
Han, J; Jenq, W; Kefalides, N A (1999) Integrin alpha2beta1 recognizes laminin-2 and induces C-erb B2 tyrosine phosphorylation in metastatic human melanoma cells. Connect Tissue Res 40:283-93
Ziaie, Z; Fawzi, A; Bellon, G et al. (1999) A peptide of the alpha3 chain of type IV collagen protects basement membrane against damage by PMN. Biochem Biophys Res Commun 261:247-50
Shahan, T A; Ohno, N; Pasco, S et al. (1999) Inhibition of tumor cell proliferation by type IV collagen requires increased levels of cAMP. Connect Tissue Res 40:221-32

Showing the most recent 10 out of 30 publications